Document is current
Any future updates will be listed below
-
Authors
Roskam, Carmen https://orcid.org/0009-0004-0144-0937
Roessler, H. Rebecca K. https://orcid.org/0000-0002-1983-916X
Medema, Jan Paul https://orcid.org/0000-0003-3045-2924
Bijlsma, Maarten F. https://orcid.org/0000-0001-6627-3229
-
Funding
Funding for this research was provided by:
Oncode Institute
- License Information
-
More Information
Article History
Received: 20 August 2025
Revised: 12 March 2026
Accepted: 11 April 2026
First Online: 12 May 2026
Competing interests
: MFB has received research funding from Celgene, Frame Therapeutics, and Lead Pharma, and has acted as a consultant to Servier, Olympus, and Wholomics. None of these parties participated in the design of this study or drafting of the manuscript. CR, HRKR, and JPM have no conflicts of interest.
